99mTc-labeled Small Molecules for Diagnosis of Alzheimer's Disease : Past, Recent and Future Perspectives
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: Alzheimer's disease (AD) is an age-related progressive neurodegenerative disease. Its prominent hallmarks are extracellular deposition of β-amyloids (amyloid plaques), intracellular neurofibrillary tangles (NTFs), neurodegeneration and finally loss of cognitive function. Hence, AD diagnosis in the early stage and monitoring of the disease are of great importance.
METHODS: In this review article, we have reviewed recent efforts for design, synthesis and evaluation of 99mTc labeled small molecule for AD imaging purposes.
RESULTS: These small molecules include derivatives of Congo red, benzothiazole, benzofuran, benzoxazole, naphthalene, biphenyl, chalcone, flavone, aurone, stilbene, curcumin, dibenzylideneacetone, quinoxaline, etc. The different aspects of 99mTc-labeled small molecules including chemical structure, their affinity toward amyloid plaques, BBB permeation and in vivo/vitro stability will be discussed.
CONCLUSION: The findings of this review confirm the importance of 99mTc-labeled small molecules for AD imaging. Future studies based on the pharmacophore of these designed compounds are needed for improvement of these molecules for clinical application.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Current medicinal chemistry - 26(2019), 12 vom: 02., Seite 2166-2189 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Molavipordanjani, Sajjad [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 23.07.2019 Date Revised 23.07.2019 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/0929867325666180410104023 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM282865845 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM282865845 | ||
003 | DE-627 | ||
005 | 20231225034931.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0929867325666180410104023 |2 doi | |
028 | 5 | 2 | |a pubmed24n0942.xml |
035 | |a (DE-627)NLM282865845 | ||
035 | |a (NLM)29637851 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Molavipordanjani, Sajjad |e verfasserin |4 aut | |
245 | 1 | 0 | |a 99mTc-labeled Small Molecules for Diagnosis of Alzheimer's Disease |b Past, Recent and Future Perspectives |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.07.2019 | ||
500 | |a Date Revised 23.07.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a BACKGROUND: Alzheimer's disease (AD) is an age-related progressive neurodegenerative disease. Its prominent hallmarks are extracellular deposition of β-amyloids (amyloid plaques), intracellular neurofibrillary tangles (NTFs), neurodegeneration and finally loss of cognitive function. Hence, AD diagnosis in the early stage and monitoring of the disease are of great importance | ||
520 | |a METHODS: In this review article, we have reviewed recent efforts for design, synthesis and evaluation of 99mTc labeled small molecule for AD imaging purposes | ||
520 | |a RESULTS: These small molecules include derivatives of Congo red, benzothiazole, benzofuran, benzoxazole, naphthalene, biphenyl, chalcone, flavone, aurone, stilbene, curcumin, dibenzylideneacetone, quinoxaline, etc. The different aspects of 99mTc-labeled small molecules including chemical structure, their affinity toward amyloid plaques, BBB permeation and in vivo/vitro stability will be discussed | ||
520 | |a CONCLUSION: The findings of this review confirm the importance of 99mTc-labeled small molecules for AD imaging. Future studies based on the pharmacophore of these designed compounds are needed for improvement of these molecules for clinical application | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a 99mTc | |
650 | 4 | |a AD imaging | |
650 | 4 | |a Alzheimer's disease | |
650 | 4 | |a SPECT | |
650 | 4 | |a small molecule | |
650 | 4 | |a β-Amyloid plaques. | |
650 | 7 | |a Amyloid beta-Peptides |2 NLM | |
650 | 7 | |a Organotechnetium Compounds |2 NLM | |
650 | 7 | |a Small Molecule Libraries |2 NLM | |
650 | 7 | |a Congo Red |2 NLM | |
650 | 7 | |a 3U05FHG59S |2 NLM | |
650 | 7 | |a Curcumin |2 NLM | |
650 | 7 | |a IT942ZTH98 |2 NLM | |
700 | 1 | |a Emami, Saeed |e verfasserin |4 aut | |
700 | 1 | |a Hosseinimehr, Seyed Jalal |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current medicinal chemistry |d 1997 |g 26(2019), 12 vom: 02., Seite 2166-2189 |w (DE-627)NLM093833857 |x 1875-533X |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2019 |g number:12 |g day:02 |g pages:2166-2189 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0929867325666180410104023 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2019 |e 12 |b 02 |h 2166-2189 |